Luna Innovations Reports First Quarter 2012 Financial Results
Â Net loss improves 67% from prior year quarter; Total revenues decrease 7% from prior year quarter; Operating expenses decrease 18% from prior year quarter
ROANOKE, Va.–(BUSINESS WIRE)–May. 9, 2012–Luna Innovations Incorporated (NASDAQ: LUNA) today announced its financial results for the first quarter endedMarch 31, 2012.
As compared to the same quarter last year, Luna improved its net loss to$0.3 millionfor the first quarter of 2012 from a net loss of$1.0 million, as lower operating expenses more than offset a decline in revenues. Total revenues decreased to$8.4 millionin the first quarter of 2012 compared to$9.0 millionin the first quarter of 2011, primarily due to lower revenues from sales of fiber optic test and measurement equipment. Gross profit decreased to$3.2 millionfor the first quarter of 2012 compared to$3.3 millionfor the first quarter of 2011.
Luna also reduced its operating expenses to$3.5 millionin the first quarter of 2012 compared to$4.2 millionin the first quarter of the prior year. Adjusted EBITDA, a non-GAAP measure, which is earnings before interest, taxes, and non-cash expenses of stock based compensation, depreciation, amortization and warrant expense, improved to$0.5 millionfor the first quarter of 2012, as compared to$0.3 millionfor the first quarter of 2011. Cash decreased to$7.9 millionatMarch 31, 2012from$8.9 millionatDecember 31, 2011.
â€œWe continue to make progress towards achieving the corporate growth strategies that we outlined late last year,â€ saidMy Chung, chief executive officer of Luna. â€œFor example, we are focusing our efforts on accelerating product sales in fiber optic sensing through ongoing development of our ODiSi platform. Secondly, we recently announced a new development agreement withPhilips Healthcare, whichÂ further strengthens our position in the medical field. And finally, we are continuing to advance our cybersecurity solutions. We remain confident that achievement of these strategies will drive long-term growth and increased shareholder value.â€
First Quarter Financial and Business Highlights
— Total revenues decreased by 7%, from$9.0 millionin the first quarter of 2011 to$8.4 millionin the first quarter of 2012.
— Products and licensing revenue decreased by 20%, from$3.4 millionin the first quarter of 2011 to$2.7 millionin the first quarter of 2012. Technology development revenues increased by 1%, to$5.7 millionfor the first quarter of 2012 from$5.6 millionfor the first quarter of 2011.
— Gross profit for the first quarter of 2012 decreased to$3.2 million, or 38% of total revenues, from$3.3 million, or 37% of total revenues, for the corresponding period of 2011.
— Selling, general and administrative expenses decreased by 25% to$2.8 million, or 33% of total revenues for the first quarter of 2012, from$3.7 million, or 41% of total revenues, for the first quarter of 2011. This decrease was attributable to a$0.4 millionreduction in our stock compensation expense, a$0.3 millionreduction in legal and other professional fees, primarily the result of a threatened proxy contest in 2011, and$0.2 millionof consulting fees to Dr.Kent Murphyincurred in the first quarter of 2011 as a result of accelerating expense recognition under our consulting agreement with him.
— Total operating expenses decreased to$3.5 million, or 42% of total revenues, for the first quarter of 2012 from$4.2 million, or 47% of total revenues for the first quarter of 2011.
— Adjusted EBITDA increased to$0.5 millionin the first quarter 2012 from$0.3 millionin the first quarter of 2011.
— Net loss attributable to common stockholders improved to$0.4 millionfor the first quarter of 2012 compared to$1.1 millionfor the first quarter of 2011.
— Cash and cash equivalents totaled$7.9 millionatMarch 31, 2012as compared to$8.9 millionatDecember 31, 2011.
— Luna extended its development and supply agreement withIntuitive Surgical, as the companies work towards the integration of Lunaâ€™s shape and position sensing technology into Intuitiveâ€™s medical robotic products.
— Luna was recognized with aU.S. Army Small Business Innovation Research(SBIR) Achievement award for its successful development of high-performance antennas for military vehicles.
— Luna announced a development agreement withPhilips Healthcareto conduct work in advancing Lunaâ€™s technology towards the commercialization of fiber-optic shape sensing in the non-robotic medical field.
Based on information as ofMay 9, 2012, Luna continues to expect total revenue for 2012 to be in the range of$32.5 million to $37.0 million. Also for 2012, we continue to anticipate a net loss to common stockholders in the range of$0.2 million to $1.2 million. For the second quarter of 2012, we expect revenue of$8.5 million to $9.0 millionand a net loss attributable to common stockholders of$0.1 million to $0.3 million.
In evaluating the operating performance of its business, Lunaâ€™s management excludes certain charges and credits that are required by generally accepted accounting principles (â€œGAAPâ€). These non-GAAP results provide useful information to both management and investors by excluding items that the company believes may not be indicative of its operating performance, because either they are unusual and the company does not expect them to recur in the ordinary course of its business or they are unrelated to the ongoing operation of the business in the ordinary course. These non-GAAP measures should be considered in addition to results and guidance prepared in accordance with GAAP, but should not be considered a substitute for, or superior to, GAAP results. The non-GAAP measures included in this press release have been reconciled to the nearest GAAP measure in the table following the financial statements attached to this press release.
Conference Call Information
As previously announced, Luna Innovationswill conduct an investor conference call at 5:00 p.m. (EDT)today to discuss its financial results and business developments for the first quarter of 2012 and expectations for the remainder of 2012. The call can be accessed by dialing 866.356.4441 domestically or 617.597.5396 internationally prior to the start of the call. The participant access code is 56519917. Investors are advised to dial in at least five minutes prior to the call to register. The conference call will also be webcast live over the Internet. The webcast can be accessed by logging on to the â€œInvestor Relationsâ€ section of the Luna Innovations website, www.lunainnovations.com, prior to the event. The webcast will be archived under the â€œWebcasts and Presentationsâ€ section of theLuna Innovations website for at least 30 days following the conference call.
About Luna Innovations:
Luna Innovations Incorporated(www.lunainnovations.com) is focused on sensing and instrumentation. Luna develops and manufactures new-generation products for the healthcare, telecommunications, energy and defense markets. The companyâ€™s products are used to measure, monitor, protect and improve critical processes in the markets it serves. Through its disciplined commercialization business model, Luna has become a recognized leader in transitioning science to solutions. Luna is headquartered inRoanoke, Virginia.
The statements in this release that are not historical facts constitute â€œforward-looking statementsâ€ made pursuant to the safe harbor provision of the Private Securities Litigation Reform Act of 1995 that involve risks and uncertainties. These statements include our expectations regarding financial results for the second quarter and full year 2012, the companyâ€™s focus on accelerating product sales in fiber optic sensing, continuing development of shape sensing technology in the medical area and advancing cybersecurity solutions, demand for the companyâ€™s fiber optic equipment and technologies, our expanded relationship with Intuitive Surgical, and our new relationship with Philips Healthcare. Management cautions the reader that these forward-looking statements are only predictions and are subject to a number of both known and unknown risks and uncertainties, and actual results, performance, and/or achievements of the company may differ materially from the future results, performance, and/or achievements expressed or implied by these forward-looking statements as a result of a number of factors. These factors include, without limitation the fact that the outlook for the second quarter of and full year 2012 could change, failure of demand for the companyâ€™s products and services to meet expectations, technological challenges, and those risks and uncertainties set forth in the companyâ€™s periodic reports and other filings with the Securities and Exchange Commission. Such filings are available at the SECâ€™s website at http://www.sec.gov, and at the companyâ€™s website at http://www.lunainnovations.com. The statements made in this release are based on information available to the company as of the date of this release andLuna Innovations undertakes no obligation to update any of the forward-looking statements after the date of this release.
|Luna Innovations Incorporated|
|Condensed Consolidated Statements of Operations|
|Â||Â||Three Months Ended|
|Products and licensing||Â||Â||2,713,814||Â||Â||Â||3,377,009||Â|
|Cost of revenues:||Â||Â||Â||Â|
|Technology development costs||Â||Â||3,902,900||Â||Â||Â||4,086,165||Â|
|Products and licensing costs||Â||Â||1,247,494||Â||Â||Â||1,572,691||Â|
|Selling, general, and administrative||Â||Â||2,800,317||Â||Â||Â||3,725,829||Â|
|Research, development, and engineering||Â||Â||695,155||Â||Â||Â||512,378||Â|
|Other expense, net||Â||Â||Â||Â|
|Other income (expense), net||Â||Â||23,265||Â||Â||Â||(1,985||)|
|Loss before income taxes||Â||Â||(328,949||)||Â||Â||(1,014,847||)|
|Income tax expense||Â||Â||5,799||Â||Â||Â||10,020||Â|
|Preferred stock dividend||Â||Â||34,096||Â||Â||Â||41,628||Â|
|Net loss attributable to common stockholders||Â||$||(368,844||)||Â||$||(1,066,495||)|
|Net loss per share of common stock:||Â||$||(0.03||)||Â||$||(0.08||)|
|Luna Innovations Incorporated|
|Condensed Consolidated Balance Sheets|
|Â||Â||March 31,||Â||December 31,|
|Cash and cash equivalents||Â||$||7,879,363||Â||Â||$||8,939,127||Â|
|Accounts receivable, net||Â||Â||6,824,530||Â||Â||Â||5,958,086||Â|
|Other current assets||Â||Â||36,796||Â||Â||Â||35,717||Â|
|Total current assets||Â||Â||18,944,762||Â||Â||Â||19,335,141||Â|
|Property and equipment, net||Â||Â||2,711,445||Â||Â||Â||2,816,674||Â|
|Intangible assets, net||Â||Â||513,656||Â||Â||Â||539,563||Â|
|Liabilities and stockholders’ equity||Â||Â||Â||Â|
|Current portion of long term debt obligation||Â||$||1,500,000||Â||Â||$||1,625,000||Â|
|Current portion of capital lease obligation||Â||Â||51,717||Â||Â||Â||50,949||Â|
|Total current liabilities||Â||Â||7,983,447||Â||Â||Â||8,407,347||Â|
|Long-term debt obligation||Â||Â||3,375,000||Â||Â||Â||3,625,000||Â|
|Long-term lease obligation||Â||Â||169,787||Â||Â||Â||183,008||Â|
|Additional paid-in capital||Â||Â||59,805,081||Â||Â||Â||59,289,516||Â|
|Total stockholders’ equity||Â||Â||10,850,881||Â||Â||Â||10,704,066||Â|
|Total liabilities and stockholders’ equity||Â||$||22,379,115||Â||Â||$||22,919,421||Â|
|Luna Innovations Incorporated|
|Condensed Consolidated Statements of Cash Flows|
|Â||Â||Three months ended|
|Cash (used in)/provided by operating activities||Â||Â||Â||Â|
Adjustments to reconcile net loss to net cash used in operating activities
|Depreciation and amortization||Â||Â||284,101||Â||Â||Â||327,413||Â|
|Changes in operating assets and liabilities:||Â||Â||Â||Â|
|Other current assets||Â||Â||139,670||Â||Â||Â||89,405||Â|
|Accounts payable and accrued expenses||Â||Â||(60,923||)||Â||Â||(384,997||)|
|Net cash (used in)/provided by operating activities||Â||Â||(546,325||)||Â||Â||609,254||Â|
|Cash flows used in investing activities||Â||Â||Â||Â|
|Acquisition of property and equipment||Â||Â||(104,719||)||Â||Â||(102,221||)|
|Intangible property costs||Â||Â||(48,246||)||Â||Â||(44,203||)|
|Net cash used in investing activities||Â||Â||(152,965||)||Â||Â||(146,424||)|
|Cash flows used in financing activities||Â||Â||Â||Â|
|Payments on capital lease obligations||Â||Â||(12,453||)||Â||Â||(5,246||)|
|Payments of debt obligations||Â||Â||(375,000||)||Â||Â||(288,523||)|
|Proceeds from exercise of options and warrants||Â||Â||26,979||Â||Â||Â||132,379||Â|
|Net cash used in financing activities||Â||Â||(360,474||)||Â||Â||(161,390||)|
|Net change in cash||Â||Â||(1,059,764||)||Â||Â||301,440||Â|
|Cash and cash equivalents, beginning of period||Â||Â||8,939,127||Â||Â||Â||7,216,580||Â|
|Cash and cash equivalents, end of period||Â||$||7,879,363||Â||Â||$||7,518,020||Â|
|Luna Innovations Incorporated|
|Reconciliation of EBITDA and Adjusted EBITDA to Net Loss|
|Â||Â||Three Months Ended March 31,|
|Depreciation and amortization||Â||Â||284,101||Â||Â||Â||Â||327,413||Â|
|Share-based compensation and warrant expense||Â||Â||466,470||Â||Â||Â||Â||841,752||Â|
Source:Luna Innovations Incorporated
Luna Innovations Incorporated
Dale Messick, CFO, 1-540-769-8400